Is MMED or ATEC more profitable?

MiniMed Group has a net margin of 0.00% compared to Alphatec's net margin of -13.49%. MiniMed Group's return on equity of 0.00% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets MiniMed Group N/A N/A N/A Alphatec -13.49% -6,752.24% -13.88%

Does the media favor MMED or ATEC?

In the previous week, Alphatec had 15 more articles in the media than MiniMed Group. MarketBeat recorded 18 mentions for Alphatec and 3 mentions for MiniMed Group. Alphatec's average media sentiment score of 0.67 beat MiniMed Group's score of 0.66 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, ATEC or LIVN?

Alphatec has higher earnings, but lower revenue than LivaNova. Alphatec is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alphatec $764.16M 1.98 -$143.36M -$0.71 N/A LivaNova $1.39B 3.26 -$242.47M $3.38 24.33

Is ATEC or LIVN more profitable?

LivaNova has a net margin of 12.82% compared to Alphatec's net margin of -13.49%. LivaNova's return on equity of 16.35% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Alphatec -13.49% -6,752.24% -13.88% LivaNova 12.82% 16.35% 7.76%

Does the media refer more to ATEC or LIVN?

In the previous week, Alphatec had 15 more articles in the media than LivaNova. MarketBeat recorded 18 mentions for Alphatec and 3 mentions for LivaNova. LivaNova's average media sentiment score of 0.89 beat Alphatec's score of 0.67 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ITGR or ATEC?

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.84B 2.31 $102.81M $3.66 34.24 Alphatec $764.16M 1.98 -$143.36M -$0.71 N/A

Is ITGR or ATEC more profitable?

Integer has a net margin of 6.97% compared to Alphatec's net margin of -13.49%. Integer's return on equity of 12.79% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% Alphatec -13.49% -6,752.24% -13.88%

Which has preferable earnings & valuation, HAE or ATEC?

Haemonetics has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Haemonetics $1.33B 3.10 $97.31M $2.04 44.54 Alphatec $764.16M 1.98 -$143.36M -$0.71 N/A

Is HAE or ATEC more profitable?

Haemonetics has a net margin of 7.12% compared to Alphatec's net margin of -13.49%. Haemonetics' return on equity of 27.55% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Haemonetics 7.12% 27.55% 9.65% Alphatec -13.49% -6,752.24% -13.88%

Does the media favor HAE or ATEC?

In the previous week, Alphatec had 2 more articles in the media than Haemonetics. MarketBeat recorded 18 mentions for Alphatec and 16 mentions for Haemonetics. Alphatec's average media sentiment score of 0.67 beat Haemonetics' score of 0.54 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 6 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to IRTC or ATEC?

In the previous week, iRhythm Technologies had 3 more articles in the media than Alphatec. MarketBeat recorded 21 mentions for iRhythm Technologies and 18 mentions for Alphatec. Alphatec's average media sentiment score of 0.67 beat iRhythm Technologies' score of 0.50 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 5 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Alphatec (ATEC) Competitors

$9.79 +0.04 (+0.41%)

Closing price 04:00 PM Eastern

Extended Trading

$9.83 +0.04 (+0.41%)

As of 05:40 PM Eastern

Compare

ATEC vs. MMED, LIVN, ITGR, HAE, and IRTC

Should you buy Alphatec stock or one of its competitors? Alphatec's main competitors and comparable companies include MiniMed Group (MMED), LivaNova (LIVN), Integer (ITGR), Haemonetics (HAE), and iRhythm Technologies (IRTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Alphatec compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Alphatec (NASDAQ:ATEC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Alphatec has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.82	-$333M	-$0.68	N/A
Alphatec	$764.16M	1.98	-$143.36M	-$0.71	N/A

MiniMed Group has a net margin of 0.00% compared to Alphatec's net margin of -13.49%. MiniMed Group's return on equity of 0.00% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Alphatec	-13.49%	-6,752.24%	-13.88%

In the previous week, Alphatec had 15 more articles in the media than MiniMed Group. MarketBeat recorded 18 mentions for Alphatec and 3 mentions for MiniMed Group. Alphatec's average media sentiment score of 0.67 beat MiniMed Group's score of 0.66 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alphatec	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiniMed Group presently has a consensus target price of $21.62, suggesting a potential upside of 7.27%. Alphatec has a consensus target price of $17.40, suggesting a potential upside of 77.73%. Given Alphatec's stronger consensus rating and higher possible upside, analysts plainly believe Alphatec is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

66.4% of Alphatec shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Alphatec beats MiniMed Group on 9 of the 14 factors compared between the two stocks.

How does Alphatec compare to LivaNova?

Alphatec (NASDAQ:ATEC) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk.

Alphatec has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Alphatec currently has a consensus price target of $17.40, suggesting a potential upside of 77.73%. LivaNova has a consensus price target of $83.50, suggesting a potential upside of 1.56%. Given Alphatec's stronger consensus rating and higher possible upside, research analysts clearly believe Alphatec is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Alphatec has higher earnings, but lower revenue than LivaNova. Alphatec is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$764.16M	1.98	-$143.36M	-$0.71	N/A
LivaNova	$1.39B	3.26	-$242.47M	$3.38	24.33

LivaNova has a net margin of 12.82% compared to Alphatec's net margin of -13.49%. LivaNova's return on equity of 16.35% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-13.49%	-6,752.24%	-13.88%
LivaNova	12.82%	16.35%	7.76%

In the previous week, Alphatec had 15 more articles in the media than LivaNova. MarketBeat recorded 18 mentions for Alphatec and 3 mentions for LivaNova. LivaNova's average media sentiment score of 0.89 beat Alphatec's score of 0.67 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alphatec	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

66.4% of Alphatec shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

LivaNova beats Alphatec on 11 of the 17 factors compared between the two stocks.

How does Alphatec compare to Integer?

Integer (NYSE:ITGR) and Alphatec (NASDAQ:ATEC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.84B	2.31	$102.81M	$3.66	34.24
Alphatec	$764.16M	1.98	-$143.36M	-$0.71	N/A

Integer presently has a consensus target price of $109.86, indicating a potential downside of 12.35%. Alphatec has a consensus target price of $17.40, indicating a potential upside of 77.73%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Integer has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market.

In the previous week, Alphatec had 18 more articles in the media than Integer. MarketBeat recorded 18 mentions for Alphatec and 0 mentions for Integer. Integer's average media sentiment score of 0.75 beat Alphatec's score of 0.67 indicating that Integer is being referred to more favorably in the media.

Company	Overall Sentiment
Integer	Positive
Alphatec	Positive

Integer has a net margin of 6.97% compared to Alphatec's net margin of -13.49%. Integer's return on equity of 12.79% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Alphatec	-13.49%	-6,752.24%	-13.88%

99.3% of Integer shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 13.5% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Integer beats Alphatec on 10 of the 16 factors compared between the two stocks.

How does Alphatec compare to Haemonetics?

Haemonetics (NYSE:HAE) and Alphatec (NASDAQ:ATEC) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

Haemonetics has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Haemonetics has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	3.10	$97.31M	$2.04	44.54
Alphatec	$764.16M	1.98	-$143.36M	-$0.71	N/A

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 66.4% of Alphatec shares are held by institutional investors. 2.1% of Haemonetics shares are held by company insiders. Comparatively, 13.5% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Alphatec had 2 more articles in the media than Haemonetics. MarketBeat recorded 18 mentions for Alphatec and 16 mentions for Haemonetics. Alphatec's average media sentiment score of 0.67 beat Haemonetics' score of 0.54 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	6 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Alphatec	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Haemonetics has a net margin of 7.12% compared to Alphatec's net margin of -13.49%. Haemonetics' return on equity of 27.55% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
Alphatec	-13.49%	-6,752.24%	-13.88%

Haemonetics currently has a consensus target price of $90.89, suggesting a potential upside of 0.03%. Alphatec has a consensus target price of $17.40, suggesting a potential upside of 77.73%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Summary

Haemonetics beats Alphatec on 10 of the 17 factors compared between the two stocks.

How does Alphatec compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Alphatec (NASDAQ:ATEC) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

iRhythm Technologies has higher earnings, but lower revenue than Alphatec. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.58	-$44.55M	-$0.43	N/A
Alphatec	$764.16M	1.98	-$143.36M	-$0.71	N/A

66.4% of Alphatec shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by company insiders. Comparatively, 13.5% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, iRhythm Technologies had 3 more articles in the media than Alphatec. MarketBeat recorded 21 mentions for iRhythm Technologies and 18 mentions for Alphatec. Alphatec's average media sentiment score of 0.67 beat iRhythm Technologies' score of 0.50 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	5 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Alphatec	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies currently has a consensus price target of $179.93, suggesting a potential upside of 42.30%. Alphatec has a consensus price target of $17.40, suggesting a potential upside of 77.73%. Given Alphatec's higher possible upside, analysts plainly believe Alphatec is more favorable than iRhythm Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

iRhythm Technologies has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

iRhythm Technologies has a net margin of -1.69% compared to Alphatec's net margin of -13.49%. iRhythm Technologies' return on equity of 10.11% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Alphatec	-13.49%	-6,752.24%	-13.88%

Summary

iRhythm Technologies beats Alphatec on 10 of the 17 factors compared between the two stocks.

Get Alphatec News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATEC vs. The Competition

Export

Metric	Alphatec	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.51B	$5.80B	$6.97B	$13.05B
Dividend Yield	N/A	1.76%	2.58%	10.72%
P/E Ratio	-13.79	26.26	269.86	25.30
Price / Sales	1.98	40.09	602.27	101.40
Price / Cash	N/A	33.59	70.53	50.75
Price / Book	-122.38	5.91	13.08	6.33
Net Income	-$143.36M	$148.67M	$3.45B	$347.70M
7 Day Performance	5.16%	1.84%	1.12%	1.07%
1 Month Performance	9.14%	4.56%	1.79%	1.03%
1 Year Performance	-37.12%	8.67%	67.69%	20.77%

Alphatec Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATEC Alphatec	3.4541 of 5 stars	$9.79 +0.4%	$17.40 +77.7%	-38.3%	$1.51B	$764.16M	N/A	700	Analyst Revision
MMED MiniMed Group	2.4148 of 5 stars	$19.10 +5.8%	$21.62 +13.2%	N/A	$5.36B	$3.10B	N/A	8,000
LIVN LivaNova	2.3492 of 5 stars	$82.46 +2.9%	$81.38 -1.3%	+54.9%	$4.40B	$1.39B	42.29	3,300
ITGR Integer	2.3128 of 5 stars	$124.45 +2.7%	$103.71 -16.7%	+14.0%	$4.12B	$1.85B	31.03	11,000	Analyst Downgrade High Trading Volume
HAE Haemonetics	1.8525 of 5 stars	$86.79 +1.5%	$78.89 -9.1%	+67.7%	$3.89B	$1.33B	42.96	3,009	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATEC) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alphatec (ATEC) Competitors

ATEC vs. MMED, LIVN, ITGR, HAE, and IRTC

How does Alphatec compare to MiniMed Group?

Summary

How does Alphatec compare to LivaNova?

Summary

How does Alphatec compare to Integer?

Summary

How does Alphatec compare to Haemonetics?

Summary

How does Alphatec compare to iRhythm Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATEC vs. The Competition

Alphatec Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alphatec (ATEC) Competitors

ATEC vs. MMED, LIVN, ITGR, HAE, and IRTC

How does Alphatec compare to MiniMed Group?

Which has stronger earnings and valuation, MMED or ATEC?

Is MMED or ATEC more profitable?

Does the media favor MMED or ATEC?

Do analysts prefer MMED or ATEC?

Do insiders and institutionals hold more shares of MMED or ATEC?

Summary

How does Alphatec compare to LivaNova?

Which has more risk and volatility, ATEC or LIVN?

Do analysts prefer ATEC or LIVN?

Which has preferable earnings and valuation, ATEC or LIVN?

Is ATEC or LIVN more profitable?

Does the media refer more to ATEC or LIVN?

Do insiders & institutionals have more ownership in ATEC or LIVN?

Summary

How does Alphatec compare to Integer?

Which has better earnings & valuation, ITGR or ATEC?

Do analysts recommend ITGR or ATEC?

Which has more risk and volatility, ITGR or ATEC?

Does the media prefer ITGR or ATEC?

Is ITGR or ATEC more profitable?

Do insiders and institutionals believe in ITGR or ATEC?

Summary

How does Alphatec compare to Haemonetics?

Which has more risk & volatility, HAE or ATEC?

Which has preferable earnings & valuation, HAE or ATEC?

Do institutionals and insiders hold more shares of HAE or ATEC?

Does the media favor HAE or ATEC?

Is HAE or ATEC more profitable?

Do analysts recommend HAE or ATEC?

Summary

How does Alphatec compare to iRhythm Technologies?

Which has higher earnings & valuation, IRTC or ATEC?

Do institutionals & insiders have more ownership in IRTC or ATEC?

Does the media refer more to IRTC or ATEC?

Do analysts prefer IRTC or ATEC?

Which has more risk and volatility, IRTC or ATEC?

Is IRTC or ATEC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATEC vs. The Competition

Alphatec Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools